CERE
Cerevel Therapeutics Holdings, Inc.
Chief Scientific Officer John Renger sold $90K of Cerevel Therapeutics Holdings, Inc.
Sold$89,777
$41.54Price
2,161Shares
−25%Stake
What CERE did after the filing
- The stock from Thu, Feb 8 close, $42.18
- 0.0%
- S&P 500, same days
- +4.9%
Measured over 30 trading days, to the Mar 22 close.
Traded Wed, Feb 7. Filed Thu, Feb 8, 2:19 PM ET, during the session. Returns use the Feb 8 close and the Mar 22 close. Not investment advice.